Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

If you’ve been struggling with unstable blood sugar, sudden energy crashes, or unexplained weight gain, Gluco6 might ...

Brown fat has long carried a kind of scientific promise. Unlike the more familiar white fat that stores energy, this darker ...

WHEN you get a tickle in your tush, the last thing you want to do is tell anyone about it. But it might surprise you to know ...

Dr. Saurabh Sethi warns that late-night dinners disrupt the body’s circadian rhythm, lowering insulin sensitivity, slowing ...

For many years, the fitness industry has sold progress in fixed time blocks. Twelve-week transformations and short challenges promise quick results and a clear endpoint. They are simple to follow and ...

A bipartisan group of senators is aiming to relieve high insulin costs for more Americans. A new bill introduced last week ...

Adults with diabetes using an automated insulin delivery system had minimal change in time in range after switching ...

Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.

Whether you’re creating legacy wealth or avoiding probate, a family trust can be a powerful tool—but it’s not right for everyone Written By Written by Staff Money Writer, WSJ | Buy Side Molly Grace is ...

Signaling is fundamental to how cells sense and respond to their environment—but in immune cells, those signals must be ...

A viral TikTok claims a simple four-ingredient combo can boost antioxidant absorption by 9x—but is it true? Dietitians ...